Sai Teja Drugs And Intermidiates Private Limited, a active private limited company, was established on 21 August 2000 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2000PTC035154. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
Formerly known as Sgvs Pharma Private Limited. It upholds a compliant status. Employing 17 professional, Its leadership includes Chandrasekhara Reddy Kallam (Director), Latha Kallam (Director), Bhargav Reddy Kallam (Director). Past directors included Addanki Siva Rama Prasad, Gade Bakki Reddy, Jaganmohanreddy Veeravenkata Nallamilli. It holds ₹8.50 Cr open charges and ₹3.86 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 39 & 40, S. V. Co-Op Industrial Estate Ida, Jeedimetla, Hyderabad, Telangana, 500055.
U24239TG2000PTC035154
035154
21 August 2000
₹2.00 Cr
₹2.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sai Teja Drugs And Intermidiates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrasekhara Reddy Kallam | Director | 07 Mar 2007 | Current |
| Latha Kallam | Director | 15 Jan 2011 | Current |
| Bhargav Reddy Kallam | Director | 27 Dec 2010 | Current |
| Saroja Konda | Director | 04 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jan 2011 | Past |
| Pramod Abcsdd | Director | 03 Jan 2011 | Past |
| Pramod Abcsdd | Director | 26 Jul 2007 | Past |
| Pramod Abcsdd | Director | 25 Jul 2007 | Past |
| Pramod Abcsdd | Director | 03 Jan 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sai Teja Drugs And Intermidiates Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.92% increase. The company also saw a substantial fall in profitability, with a 177.96% decrease in profit. The company's net worth dipped by a decrease of 9.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sai Teja Drugs And Intermidiates's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹85,000,000.00
₹38,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 2012 | Bank Of Baroda | ₹8.50 Cr | Open |
| 26 Mar 2009 | Andhra Pradesh State Financial Corporation | ₹3.06 Cr | Satisfied |
| 29 Apr 2004 | Lord Krishna Bank Ltd | ₹5.00 M | Satisfied |
| 19 Aug 2002 | Andhra Bank | ₹1.00 M | Satisfied |
| 15 Mar 2002 | Andhra Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Sai Teja Drugs And Intermidiates has a workforce of 17 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sai Teja Drugs And Intermidiates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Teja Drugs And Intermidiates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sai Teja Drugs And Intermidiates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Saroja Konda was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity Sai Teja Drugs And Intermidiates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge with Bank Of Baroda of Rs. 8.50 Cr registered on 15 Nov 2012 with Charge ID 10390650 was modified on 01 Mar 2013. was documented.
A charge registered on 26 Mar 2009 via Charge ID 10153476 with Andhra Pradesh State Financial Corporation was fully satisfied on 23 Nov 2012. was recorded as a recent event.
Progress on A charge with Bank Of Baroda amounted to Rs. 8.50 Cr with Charge ID 10390650 was registered on 15 Nov 2012. was documented.
The CIN of Sai Teja Drugs And Intermidiates Private Limited is U24239TG2000PTC035154.
Sai Teja Drugs And Intermidiates Private Limited is headquartered at Plot No 39 & 40, S. V. Co-Op Industrial Estate Ida, Jeedimetla, Hyderabad, Telangana, 500055.
Sai Teja Drugs And Intermidiates Private Limited was incorporated on 21 August 2000.
The current directors of Sai Teja Drugs And Intermidiates Private Limited are
The primary industry of Sai Teja Drugs And Intermidiates Private Limited is Manufacturing.
Sai Teja Drugs And Intermidiates Private Limited is unlisted.
The authorized capital of Sai Teja Drugs And Intermidiates Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Sai Teja Drugs And Intermidiates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX